Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02653
Species: Homo sapiens
Position : chr6:31139599-31139921
Year: 2016
Title: A new class of temporarily phenotypic enhancers identified by CRISPR/Cas9-mediated genetic screening.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
PMID:  26813977
Tissue: embryo
Tissue Ontology ID: UBERON:0000922
Cell Source: WA01
CVCL ID: CVCL_9771
Cell Type: embryonic stem cell
Cell Ontology ID: CL:0002322
Experiment Type: High-throughput cis-regulatory screen; enhancer activity assay; endogenous enhancer deletion; Endogenous enhancer perturbation
High Throughput Method: Pooled CRISPR-Cas9 screen; DNase-seq and ENCODE chromatin-data integration; CRISPR genetic screen
Low Throughput Method: Luciferase reporter assay; individual CRISPR-Cas9 enhancer deletion; flow cytometry; qRT-PCR; CRISPR-Cas9 endogenous deletion/editing
About Target Gene
Target gene : POU5F1
About TF
TF name : POU5F1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
POU5F1 HIF-2-alpha transcription factor network pid 34
POU5F1 POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation reactome 13
POU5F1 POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation reactome 10
POU5F1 Transcriptional regulation of pluripotent stem cells reactome 28
POU5F1 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
POU5F1 Hs_Wnt_Signaling_Pathway_and_Pluripotency_WP399_90291 wikipathways 12
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_01747 chr6:31139519-31140167 NA NA NA
E_02654 chr6:31139599-31139921 embryonic stem-cell culture embryonic stem cell NA
E_02663 chr6:31139599-31139921 NA NA NA
Expression of Target Genes for the Enhancer